Magnus Financial Group’s Insys Therapeutics, Inc. INSY Stock Holding History
Bought
Maintained
Sold
Other funds holding INSY
WS
Magnus Financial Group's INSY Position: Q2 2019 in Review
Magnus Financial Group sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 13,393 shares — an estimated $62K sold.
Magnus Financial Group first reported a position in INSY in Q4 2018 and held it in 2 quarters. The position peaked at $62K in Q1 2019. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.
- Magnus Financial Group reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
- Magnus Financial Group sold 13,393 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $62K.
- Magnus Financial Group first reported a position in Insys Therapeutics, Inc. in Q4 2018 and held it in 2 quarters.
- Magnus Financial Group's Insys Therapeutics, Inc. position peaked at $62K in Q1 2019.
- 16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.
Based on Magnus Financial Group's 13F filing for Q2 2019, filed 5 Aug 2019.